カテゴリー： 世界, 医療/バイオ, FactMR

世界の股関節腱炎市場2023-2033：怪我別（股関節内反、股関節外反、関節内スナップヒップ）、治療法別（診断、治療）、エンドユーザー別（病院＆クリニック、医療研究センター、学術機関）、地域別

【英語タイトル】Hip Tendinitis Market Analysis, By Injury Type (Internal Snapping Hip, External Snapping Hip, Intra-articular Snapping Hip), By Treatment (Diagnosis, Therapy), By End User (Hospitals & Clinics, Medical Research Centers, Academic Institutes), & By Region - Global Market Insights 2023 to 2033

FactMRが出版した調査資料（FACT23MA117）・商品コード：FACT23MA117
・発行会社（調査会社）：FactMR
・発行日：2023年3月31日
・ページ数：約170
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
Global Site License（同一拠点内共有可）USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Fact.MR社の本調査レポートでは、世界の股関節腱炎市場について2023年から2033年までの市場動向を分析・予測しています。当レポートは、エグゼクティブサマリー、市場概要、市場リスク・動向分析、市場背景・基礎データポイント、市場需要分析・予測、怪我別（股関節内反、股関節外反、関節内スナップヒップ）分析、治療法別（診断、治療）分析、エンドユーザー別（病院＆クリニック、医療研究センター、学術機関）分析、地域別（北米、中南米、ヨーロッパ、東アジア、南アジア＆オセアニア、中東＆アフリカ）分析、市場構造分析、競争状況などの構成でまとめています。なお、企業情報として、VFO、Amedia Corporation、Dolphin Computer Access Ltd.、HumanWare Groupなどが含まれています。
・エグゼクティブサマリー
・市場概要
・市場リスク・動向分析
・市場背景・基礎データポイント
・市場需要分析・予測
・世界の股関節腱炎市場規模：怪我別
- 股関節内反の市場規模
- 股関節外反の市場規模
- 関節内スナップヒップの市場規模
・世界の股関節腱炎市場規模：治療法別
- 診断の市場規模
- 治療の市場規模
・世界の股関節腱炎市場規模：エンドユーザー別
- 病院＆クリニックにおける市場規模
- 医療研究センターにおける市場規模
- 学術機関における市場規模
・世界の股関節腱炎市場規模：地域別
- 北米の股関節腱炎市場規模
- 中南米の股関節腱炎市場規模
- ヨーロッパの股関節腱炎市場規模
- 東アジアの股関節腱炎市場規模
- 南アジア＆オセアニアの股関節腱炎市場規模
- 中東＆アフリカの股関節腱炎市場規模
・市場構造分析
・競争状況

本レポートには、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などの要素を含む企業情報が含まれています。企業のプレゼンスは、全著名プレーヤーについてマッピングされ、マトリックスを通して提示されます。なお、購読者に実用的な洞察を提供し、熟考して市場の状況を示し、股関節腱炎における競争レベルを推測するのに役立ちます。

Hip Tendinitis Market – Scope of Report

A recent study by Fact.MR on the hip tendinitis market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering hip tendinitis.

The study also provides the dynamics responsible for influencing the future status of the hip tendinitis market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the hip tendinitis market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of hip tendinitis across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of hip tendinitis during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for hip tendinitis are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global hip tendinitis market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the hip tendinitis market during the forecast period.

Country-specific valuation on demand for hip tendinitis has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of hip tendinitis, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering hip tendinitis has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the hip tendinitis domain.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1. Global Market – Executive Summary

    1.1. Global Market Overview

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Fact.MR Analysis and Recommendations

2. Global Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Introduction and Definition

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Hip Tendinitis

        3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices

        3.1.3. COVID-19 Impact Benchmark with Previous Crisis

            3.1.3.1. Change in Demand

            3.1.3.2. Before and After COVID-19 Crisis (Projected)

            3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual)

            3.1.3.4. Change in Demand post Recovery Period (After Each Crisis)

        3.1.4. Impact on Market and Value (US$ Mn)

            3.1.4.1. Likely Loss of Value in 2022

            3.1.4.2. Mid-term and Long Term Forecast

            3.1.4.3. Quarter by Quarter Demand and Recovery Assessment

        3.1.5. Anticipated Demand and Value Recovery Curve

            3.1.5.1. Likelihood of U-Shape Recovery

            3.1.5.2. Likelihood of L-Shape Recovery

        3.1.6. Recovery Period Assessment by Key Countries

        3.1.7. Recovery Assessment by Key Market Segments

        3.1.8. Action Points and Recommendations for Suppliers

        3.1.9. Impact on Trade Balance

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Source Development Trends

4. Market Background and foundation Data Points

    4.1. Need of the Hour for Industries

    4.2. Industry Wise Industry 4.0

    4.3. Strategic Priorities

    4.4. Life Cycle Stage

    4.5. Importance of Technology

    4.6. Use Cases of Hip Tendinitis

    4.7. Forecast Factors: Relevance and Impact

    4.8. Investment Feasibility Matrix

    4.9. PESTLE Analysis

    4.10. Porter’s Five Forces Analysis

    4.11. Market Dynamics

        4.11.1. Drivers

        4.11.2. Restraints

        4.11.3. Opportunity Analysis

        4.11.4. Trend

5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033

    5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2022

    5.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Injury Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Value (US$ Mn) Analysis By Injury Type, 2018 to 2022

    6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Injury Type, 2023 to 2033

        6.3.1. Internal Snapping Hip

        6.3.2. External Snapping Hip

        6.3.3. Intra-articular Snapping Hip

    6.4. Market Attractiveness Analysis By Injury Type

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Treatment

    7.1. Introduction / Key Findings

    7.2. Historical Market Value (US$ Mn) Analysis By Treatment , 2018 to 2022

    7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Treatment, 2023 to 2033

        7.3.1. Diagnosis

        7.3.2. Therapy

    7.4. Market Attractiveness Analysis By Treatment

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Value (US$ Mn) Analysis By End User, 2018 to 2022

    8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2023 to 2033

        8.3.1. Hospitals & Clinics

        8.3.2. Medical Research Centers

        8.3.3. Academic Institutes

    8.4. Market Attractiveness Analysis By End User

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region

    9.1. Introduction / Key Findings

    9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2022

    9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. East Asia

        9.3.5. South Asia & Oceania

        9.3.6. Middle East and Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    10.1. Introduction / Key Findings

    10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033

        10.3.1. By Country

            10.3.1.1. United States

            10.3.1.2. Canada

        10.3.2. By Injury Type

        10.3.3. By Treatment

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Injury Type

        10.4.3. By Treatment

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        11.3.1. By Country

            11.3.1.1. Brazil

            11.3.1.2. Mexico

            11.3.1.3. Rest of Latin America

        11.3.2. By Injury Type

        11.3.3. By Treatment

        11.3.4. By End User

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Injury Type

        11.4.3. By Treatment

        11.4.4. By End User

12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        12.3.1. By Country

            12.3.1.1. Germany

            12.3.1.2. France

            12.3.1.3. Italy

            12.3.1.4. Spain

            12.3.1.5. United Kingdom

            12.3.1.6. BENELUX

            12.3.1.7. Russia

            12.3.1.8. Rest of Europe

        12.3.2. By Injury Type

        12.3.3. By Treatment

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Injury Type

        12.4.3. By Treatment

        12.4.4. By End User

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        13.3.1. By Country

            13.3.1.1. China

            13.3.1.2. Japan

            13.3.1.3. South Korea

        13.3.2. By Injury Type

        13.3.3. By Treatment

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Injury Type

        13.4.3. By Treatment

        13.4.4. By End User

14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Malaysia

            14.3.1.4. Singapore

            14.3.1.5. Vietnam

            14.3.1.6. ANZ

            14.3.1.7. Rest of South Asia & Oceania

        14.3.2. By Injury Type

        14.3.3. By Treatment

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Injury Type

        14.4.3. By Treatment

        14.4.4. By End User

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    15.1. Introduction / Key Findings

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. GCC Countries

            15.3.1.2. South Africa

            15.3.1.3. Israel

            15.3.1.4. Rest of Middle East and Africa (MEA)

        15.3.2. By Injury Type

        15.3.3. By Treatment

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Injury Type

        15.4.3. By Treatment

        15.4.4. By End User

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

    16.4. Market Presence Analysis

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive

        17.3.1. Almatica Pharma, Inc

            17.3.1.1. Company Overview

            17.3.1.2. Source overview

            17.3.1.3. SWOT Analysis

            17.3.1.4. Key Developments

        17.3.2. AstraZeneca

            17.3.2.1. Company Overview

            17.3.2.2. Source overview

            17.3.2.3. SWOT Analysis

            17.3.2.4. Key Developments

        17.3.3. Bayer AG

            17.3.3.1. Company Overview

            17.3.3.2. Source overview

            17.3.3.3. SWOT Analysis

            17.3.3.4. Key Developments

        17.3.4. Boehringer Ingelheim Pharmaceuticals, Inc

            17.3.4.1. Company Overview

            17.3.4.2. Source overview

            17.3.4.3. SWOT Analysis

            17.3.4.4. Key Developments

        17.3.5. Merck & Co., Inc

            17.3.5.1. Company Overview

            17.3.5.2. Source overview

            17.3.5.3. SWOT Analysis

            17.3.5.4. Key Developments

        17.3.6. Pfizer

            17.3.6.1. Company Overview

            17.3.6.2. Source overview

            17.3.6.3. SWOT Analysis

            17.3.6.4. Key Developments

        17.3.7. Abbott

            17.3.7.1. Company Overview

            17.3.7.2. Source overview

            17.3.7.3. SWOT Analysis

            17.3.7.4. Key Developments

        17.3.8. GlaxoSmithKline plc

            17.3.8.1. Company Overview

            17.3.8.2. Source overview

            17.3.8.3. SWOT Analysis

            17.3.8.4. Key Developments

        17.3.9. Teva Pharmaceuticals

            17.3.9.1. Company Overview

            17.3.9.2. Source overview

            17.3.9.3. SWOT Analysis

            17.3.9.4. Key Developments

        17.3.10. Lupin Pharmaceuticals, Inc.

            17.3.10.1. Company Overview

            17.3.10.2. Source overview

            17.3.10.3. SWOT Analysis

            17.3.10.4. Key Developments

        17.3.11. Geri-Care Pharmaceuticals.

            17.3.11.1. Company Overview

            17.3.11.2. Source overview

            17.3.11.3. SWOT Analysis

            17.3.11.4. Key Developments

        17.3.12. Perrigo Company

            17.3.12.1. Company Overview

            17.3.12.2. Source overview

            17.3.12.3. SWOT Analysis

            17.3.12.4. Key Developments

18. Assumptions And Acronyms Used

19. Research Methodology



★調査レポート[世界の股関節腱炎市場2023-2033：怪我別（股関節内反、股関節外反、関節内スナップヒップ）、治療法別（診断、治療）、エンドユーザー別（病院＆クリニック、医療研究センター、学術機関）、地域別] (コード：FACT23MA117)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の股関節腱炎市場2023-2033：怪我別（股関節内反、股関節外反、関節内スナップヒップ）、治療法別（診断、治療）、エンドユーザー別（病院＆クリニック、医療研究センター、学術機関）、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の胸腺がん治療市場（~2033）：がん種類別（胸腺腫、胸腺がん）、治療法別（手術、放射線療法、化学療法、ホルモン療法、標的療法、免疫療法）、エンドユーザー別（病院＆クリニック、研究＆学術機関）、流通チャネル別（病院薬局、小売薬局、オンライン薬局）、地域別
  • 世界の矮小歯治療市場（~2033）：種類別（真性汎発性矮小歯、相対的汎発性矮小歯、限局性矮小歯）、治療法別（審美、修復、矯正）、エンドユーザー別（歯科医院、歯科技工所）、地域別
  • 世界の耳感染症治療市場2023年-2032年：感染症別（内耳、中耳、外耳）、病原体別（細菌、ウイルス、真菌）、治療法別（薬剤、手術）、エンドユーザー別（病院、クリニック、その他）
  • 世界の慢性特発性便秘治療市場2023-2033：種類別（正常通過性便秘、緩徐通過性便秘）、治療法別（薬物療法、非薬物療法）、治療別（投薬、手術）、薬剤別（セロトニン4（5-Ht4）受容体作動薬、グアニル酸シクラーゼCアゴニスト、下剤、興奮剤）、投与経路別（経口、注射）、エンドユーザー別（病院、在宅医療、専門クリニック）、地域別
  • 世界のレフサム病治療市場2023-2033：種類別（手術、投薬）、エンドユーザー別（病院、クリニック、研究センター、在宅ケア）、患者年齢層別（小児、成人）、地域別
  • 世界の感覚障害治療市場2023-2033：種類別（急性知覚異常、慢性知覚異常）、治療別（免疫抑制薬、抗けいれん薬、トロピカルクリーム、抗ウイルス薬）、エンドユーザー別（病院、クリニック、診断センター）、地域別
  • 世界の血液診断市場2023-2031：製品タイプ別（血液学機器、血液学消耗品）、エンドユーザー別（診断ラボ、病院・クリニック、学術機関、その他）
  • 世界のqPCR試薬市場2023-2033：検出方法別（色素ベース、プローブ＆プライマーベース）、包装タイプ別（qPCRコアキット、qPCRマスターミックス）、用途別（診断、研究、科学捜査）、エンドユーザー別（病院＆診断センター、研究所＆学術機関、その他）、地域別
  • 世界の医療シミュレーション市場（2023-2033）：製品＆サービス別（医療シミュレーションソフトウェア、ウェブベースシミュレータ、シミュレーショントレーニングサービス）、技術別（仮想患者シミュレーション、3Dプリンティング、処置リハーサル技術）、エンドユーザー別（病院、学術機関、軍事機関、研究）、地域別
  • 世界のMRI誘導神経外科アブレーション市場2023-2033：製品別（RFアブレーションシステム、レーザーアブレーションシステム、集束超音波システム、付属品）、エンドユーザー別（病院、外来手術センター、クリニック、研究室）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆